The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nasal Delivery-Global Market Insights and Sales Trends 2024
Synopsis
The global Nasal Delivery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nasal Delivery in various end use industries. The expanding demands from the Allergic And Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications, are propelling Nasal Delivery market. Sprays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drops & Liquids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nasal Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nasal Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nasal Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nasal Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nasal Delivery covered in this report include Merck & Co., Inc., Novartis AG, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Pfizer Inc., 3M, Becton, Dickinson and Company, Aegis Therapeutics LLC and Aptargroup, Inc., etc.
The global Nasal Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co., Inc.
Novartis AG
Glaxosmithkline PLC
Johnson & Johnson Services, Inc.
Pfizer Inc.
3M
Becton, Dickinson and Company
Aegis Therapeutics LLC
Aptargroup, Inc.
Astrazeneca
Global Nasal Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nasal Delivery market, Segment by Type:
Sprays
Drops & Liquids
Powders
Gels
Global Nasal Delivery market, by Application
Allergic And Non-allergic Rhinitis
Nose Congestion
Vaccination
Other Therapeutic Applications
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nasal Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Nasal Delivery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nasal Delivery in various end use industries. The expanding demands from the Allergic And Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications, are propelling Nasal Delivery market. Sprays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drops & Liquids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nasal Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nasal Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nasal Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nasal Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nasal Delivery covered in this report include Merck & Co., Inc., Novartis AG, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Pfizer Inc., 3M, Becton, Dickinson and Company, Aegis Therapeutics LLC and Aptargroup, Inc., etc.
The global Nasal Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co., Inc.
Novartis AG
Glaxosmithkline PLC
Johnson & Johnson Services, Inc.
Pfizer Inc.
3M
Becton, Dickinson and Company
Aegis Therapeutics LLC
Aptargroup, Inc.
Astrazeneca
Global Nasal Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nasal Delivery market, Segment by Type:
Sprays
Drops & Liquids
Powders
Gels
Global Nasal Delivery market, by Application
Allergic And Non-allergic Rhinitis
Nose Congestion
Vaccination
Other Therapeutic Applications
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nasal Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nasal Delivery
1.1 Nasal Delivery Market Overview
1.1.1 Nasal Delivery Product Scope
1.1.2 Nasal Delivery Market Status and Outlook
1.2 Global Nasal Delivery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nasal Delivery Market Size by Region (2018-2029)
1.4 Global Nasal Delivery Historic Market Size by Region (2018-2023)
1.5 Global Nasal Delivery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nasal Delivery Market Size (2018-2029)
1.6.1 North America Nasal Delivery Market Size (2018-2029)
1.6.2 Europe Nasal Delivery Market Size (2018-2029)
1.6.3 Asia-Pacific Nasal Delivery Market Size (2018-2029)
1.6.4 Latin America Nasal Delivery Market Size (2018-2029)
1.6.5 Middle East & Africa Nasal Delivery Market Size (2018-2029)
2 Nasal Delivery Market by Type
2.1 Introduction
2.1.1 Sprays
2.1.2 Drops & Liquids
2.1.3 Powders
2.1.4 Gels
2.2 Global Nasal Delivery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nasal Delivery Historic Market Size by Type (2018-2023)
2.2.2 Global Nasal Delivery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nasal Delivery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nasal Delivery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nasal Delivery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nasal Delivery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nasal Delivery Revenue Breakdown by Type (2018-2029)
3 Nasal Delivery Market Overview by Application
3.1 Introduction
3.1.1 Allergic And Non-allergic Rhinitis
3.1.2 Nose Congestion
3.1.3 Vaccination
3.1.4 Other Therapeutic Applications
3.2 Global Nasal Delivery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nasal Delivery Historic Market Size by Application (2018-2023)
3.2.2 Global Nasal Delivery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nasal Delivery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nasal Delivery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nasal Delivery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nasal Delivery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nasal Delivery Revenue Breakdown by Application (2018-2029)
4 Nasal Delivery Competition Analysis by Players
4.1 Global Nasal Delivery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nasal Delivery as of 2022)
4.3 Date of Key Players Enter into Nasal Delivery Market
4.4 Global Top Players Nasal Delivery Headquarters and Area Served
4.5 Key Players Nasal Delivery Product Solution and Service
4.6 Competitive Status
4.6.1 Nasal Delivery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck & Co., Inc.
5.1.1 Merck & Co., Inc. Profile
5.1.2 Merck & Co., Inc. Main Business
5.1.3 Merck & Co., Inc. Nasal Delivery Products, Services and Solutions
5.1.4 Merck & Co., Inc. Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.1.5 Merck & Co., Inc. Recent Developments
5.2 Novartis AG
5.2.1 Novartis AG Profile
5.2.2 Novartis AG Main Business
5.2.3 Novartis AG Nasal Delivery Products, Services and Solutions
5.2.4 Novartis AG Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis AG Recent Developments
5.3 Glaxosmithkline PLC
5.3.1 Glaxosmithkline PLC Profile
5.3.2 Glaxosmithkline PLC Main Business
5.3.3 Glaxosmithkline PLC Nasal Delivery Products, Services and Solutions
5.3.4 Glaxosmithkline PLC Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Services, Inc. Recent Developments
5.4 Johnson & Johnson Services, Inc.
5.4.1 Johnson & Johnson Services, Inc. Profile
5.4.2 Johnson & Johnson Services, Inc. Main Business
5.4.3 Johnson & Johnson Services, Inc. Nasal Delivery Products, Services and Solutions
5.4.4 Johnson & Johnson Services, Inc. Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Services, Inc. Recent Developments
5.5 Pfizer Inc.
5.5.1 Pfizer Inc. Profile
5.5.2 Pfizer Inc. Main Business
5.5.3 Pfizer Inc. Nasal Delivery Products, Services and Solutions
5.5.4 Pfizer Inc. Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Inc. Recent Developments
5.6 3M
5.6.1 3M Profile
5.6.2 3M Main Business
5.6.3 3M Nasal Delivery Products, Services and Solutions
5.6.4 3M Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.6.5 3M Recent Developments
5.7 Becton, Dickinson and Company
5.7.1 Becton, Dickinson and Company Profile
5.7.2 Becton, Dickinson and Company Main Business
5.7.3 Becton, Dickinson and Company Nasal Delivery Products, Services and Solutions
5.7.4 Becton, Dickinson and Company Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.7.5 Becton, Dickinson and Company Recent Developments
5.8 Aegis Therapeutics LLC
5.8.1 Aegis Therapeutics LLC Profile
5.8.2 Aegis Therapeutics LLC Main Business
5.8.3 Aegis Therapeutics LLC Nasal Delivery Products, Services and Solutions
5.8.4 Aegis Therapeutics LLC Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.8.5 Aegis Therapeutics LLC Recent Developments
5.9 Aptargroup, Inc.
5.9.1 Aptargroup, Inc. Profile
5.9.2 Aptargroup, Inc. Main Business
5.9.3 Aptargroup, Inc. Nasal Delivery Products, Services and Solutions
5.9.4 Aptargroup, Inc. Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.9.5 Aptargroup, Inc. Recent Developments
5.10 Astrazeneca
5.10.1 Astrazeneca Profile
5.10.2 Astrazeneca Main Business
5.10.3 Astrazeneca Nasal Delivery Products, Services and Solutions
5.10.4 Astrazeneca Nasal Delivery Revenue (US$ Million) & (2018-2023)
5.10.5 Astrazeneca Recent Developments
6 North America
6.1 North America Nasal Delivery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nasal Delivery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nasal Delivery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nasal Delivery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nasal Delivery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nasal Delivery Market Dynamics
11.1 Nasal Delivery Industry Trends
11.2 Nasal Delivery Market Drivers
11.3 Nasal Delivery Market Challenges
11.4 Nasal Delivery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
